Genome Sequencing in Newborns May Identify Life-Threatening Disorders Missed by Traditional Tests: Study Shows
Written By : Dr. Bhumika Maikhuri
Published On 2025-10-11 03:00 GMT | Update On 2025-10-11 09:21 GMT
Advertisement
A recent study published in Nature Medicine has revealed that adding genomic sequencing to Australia's standard newborn blood screening could dramatically improve early diagnosis and treatment for hundreds of severe childhood conditions.
The BabyScreen+ study demonstrated that using genomic sequencing, which maps a baby’s entire genetic code, could expand screening to detect hundreds of serious, treatable disorders. The test, using the same blood sample already collected for standard screening, returned results within 14 days.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.